Take Turkey, take Argentina, take Pakistan and some of the other higher inflationary areas around the world. We took pricing in the second quarter in North America. Obviously, that had some impact on volume in the quarter. But we’ll see deliberate and very focused pricing where we have margin pressure. On the Hill’s business, clearly, we’ve seen ag prices accelerate through 2022 and into ’23. So we’re taking pricing commensurate with that as we move into the back half. But it will be more isolated and targeted the bigger price increases are in the P&L. And as you heard us talk about, we took a lot of pricing in 2022. About 58% of the pricing in the P&L this year is flow through from last year. So we still have a little bit to go, but most of it is in the P&L already.
Operator: Our next question will come from Bryan Spillane of Bank of America. Please go ahead.
Bryan Spillane: Hey. Thanks, operator. Good morning, everyone. Hey, Noel. Maybe just kind of tying it back to — maybe this ties back to Dara’s question. But in the prepared remarks, you talked about — on a percentage of sales basis, SG&A would be up in North America, Europe and Hill’s to support volume acceleration. And I guess, as we look through the results, it looks like it’s been pretty good in Europe, like, you’ve gained share. So maybe if you can, for some context, in terms of that investment, how much of it is – like, where has each of those geographies progressed relative to the investment? Is it right to read that you’re having an impact in Europe and you still have some catch-up to do in North America? Just want to get some color on that.
Noel Wallace: Absolutely. Thanks, Bryan. Yeah. I’ll start with Europe. Obviously, we’ve increased investment there and we’re seeing terrific response to particularly the elmex and meridol brands where we’ve elevated our investment there, but likewise, on the Colgate brand. So a lot of the efforts that we’ve had on premium whitening have played out to drive incremental share in Europe. So that investment across that business is certainly playing out. But importantly, the investment in Europe is broader based than just Oral Care. We have a wonderful relaunch on Sanex, that’s underway across Europe. We’re putting investment behind that. We relaunched our Soupline business in France, which is a big business for us. And we’ve launched the Suavitel — the Soupline Hearts, which we’re putting investment behind that.
So I think what’s important is with operating margins back to growth, it’s giving us a lot more flexibility to support a wide array of brands, particularly in Europe. And that would be the case likewise in Latin America, where we’ve obviously seen a little pickup in exchange. So on a local currency basis, we’re getting more advertising. And I’d also point to the fact that we’re getting more efficient and targeted with our advertising with some of our digital skills that we’re implementing across the world. North America, it’s taking a little bit more time. You certainly have seen the promoted share fall off. But as I mentioned in my comments to Dara, the important thing is our non-promoted volume share is growing. And that’s a clear reflection of the fact that we’ve increased support on the brand and building the health of the brand.
And if you look at the attributes of the Colgate brand, particularly in North America, we’re seeing good movements in terms of how we measure the health of the equity. So good news there. Asia, likewise, good response. We’ve obviously seen a fall-off on our biggest business, which is Darlie due to the price increase. But the Colgate business overall, where we’ve added more support similarly is responding very, very well. And we couldn’t be more happy with the progress we’re seeing in Africa on the Oral Care business with the elevated increase that we’re seeing. Advertising doesn’t respond immediately. It takes quarters after quarters of consistent growth. And what’s important, back to the quality of the P&L, is that with the quality of the P&L where it is, it allows us to sustain that advertising.
